· In the News

Health Medicine Network: HMN 2025: How to link blood proteins to Alzheimer’s disease and memory loss

Researchers at Emory Goizueta Brain Health Institute and partner institutions have found new clues in the blood that could help explain why Alzheimer’s disease develops and how it affects memory. The study, published in Nature Aging, examined blood samples from more than 2,100 individuals across four large research cohorts. Using advanced tools, scientists measured thousands of proteins in […]

· In the News

MSN/Medical Xpress: New study links blood proteins to Alzheimer’s disease and memory loss

Story by Ronna Charles • 2 min read Researchers at Emory Goizueta Brain Health Institute and partner institutions have found new clues in the blood that could help explain why Alzheimer’s disease develops and how it affects memory.The study, published in Nature Aging, examined blood samples from more than 2,100 individuals across four large research cohorts. […]

· In the News

TrialSite News: GAP Foundation Aims to Improve Speed and Efficiency of Alzheimer’s Trials: An Interview with President John Dwyer

trialsitenews, Aug. 28, 2025, 12:30 p.m. September is Alzheimer’s Awareness Month, a time to reflect on the devastating impact of Alzheimer’s disease and the urgent need for better treatments and care. More than 6 million Americans are living with Alzheimer’s, a number expected to climb steeply in the coming decades. As the need grows, so […]

· In the News

ALZ Forum: Roche Spells Out Phase Three Plans for Trontinemab

22 Aug 2025 The current Alzheimer’s disease therapeutic antibodies carry a sizable risk of ARIA, especially for APOE4 carriers. Researchers believe the future of amyloid immunotherapies lies in targeted brain delivery that bypasses the larger blood vessels prone to this side effect, and several companies are working on this. At the Alzheimer’s Association International Conference, […]

· In the News

Dementia Help: Accelerating Alzheimer’s Research: The Bio-Hermes-001 Dataset is Now Publicly Available

The Global Alzheimer’s Platform Foundation (GAP) and the Alzheimer’s Disease Data Initiative (AD Data Initiative) have released the Bio?Hermes?001 dataset — described as the most comprehensive biomarker dataset in Alzheimer’s research history. The release of Bio?Hermes?001 marks a pivotal moment in Alzheimer’s research: a first?of?its?kind dataset blending biomarker, cognitive, retinal, and speech data across a deeply diverse cohort. Now available to scientists worldwide, […]

· In the News

AInvest: Roche’s Alzheimer’s Prevention Gambit: A Game-Changer in a $13B Market?

OliverBlake, Sunday, Jul 27, 2025 4:21 pm ETThe global Alzheimer’s disease market is a high-stakes arena where innovation and precision collide. With over 60 million people affected worldwide and a projected $19.44 billion market size by 2030, the race to develop disease-modifying therapies (DMTs) and diagnostics is intensifying. Roche, a pharmaceutical giant with a legacy […]

· In the News

BioSpace: Alzheimer’s Disease Diagnostics Market Size to Reach USD 25.53 Billion by 2034

June 30, 2025 | 1 min read The global alzheimer’s disease diagnostics market size is calculated at USD 8.95 billion in 2024, grows to USD 9.94 billion in 2025, and is projected to reach around USD 25.53 billion by 2034, growing at a CAGR of 11.05% from 2025 to 2034. Rising regulatory approvals, innovative product launches, research funding […]

· In the News

WPRI: Bridging the gap: How Progreso Latino is changing the face of Alzheimer’s research

by: Alex Torres-Perez, Posted: Jun 30, 2025 CENTRAL FALLS, R.I. (WPRI) — Central Falls-based Progreso Latino has been awarded the Global Alzheimer’s Platform Foundation’s prestigious Citizen Scientist Cultivator Award for its work bridging barriers to get more Hispanic people involved in Alzheimer’s studies, which could help millions in the future. Studies show Hispanics are 1.5 times more […]

· In the News

Families demand end to Medicare waiting period for early-onset Alzheimer’s patients

This article was originally published in the Washington Examiner by Elaine Mallon Jason Raubach was diagnosed at 50 years old with early-onset Alzheimer’s disease — a diagnosis that affects nearly 200,000 Americans. He received the diagnosis in 2018, completely upending life for his family. His youngest child was just a freshman in high school. “It’s like somebody grabs you by […]

· In the News

The Chicago Defender: Hundreds Attend Free Brain Health Day in Chicago to Combat Alzheimer’s Disparities

May 10, 2025 Chicago Bulls Guard Jahmir Young (left) Senator Mattie Hunter (middle) and Dr. Rany Aburashed, CEO of Neurogen Biomarking (right) rallied over 400 community members during a free Brain Health Day sponsored by Neurogen at Insight Hospital (Photo Provided).  On Saturday, more than 400 community members participated in Capturing Memories: A Free Brain Health […]

· In the News

Health Digest: This US County Has One Of The Highest Dementia Rates In The Country And The Reasons Are Heartbreaking

BY NANCY SCHIMELPFENING MAY 12, 2025 3:30 PM EST Alzheimer’s disease is a form of dementia that affects memory, thinking, and behavior severely enough to interfere with daily life. While certain treatments may slow its progression, there is currently no cure. (Here are some warning signs of Alzheimer’s disease you should never ignore.) According to The South […]

· In the News

New York Post: This Texas county has one of the highest dementia rates in the US — what’s behind it?

By  Diana Bruk Published May 1, 2025, 3:10 p.m. A county in southern Texas, near the US-Mexico border, is suffering from a bit of an epidemic. Starr County has emerged as a national hot spot — not for tourism or industry, but for having one of the highest rates of dementia in the country. Roughly one in five seniors […]

· In the News

Daily Mail EXCLUSIVE: Unassuming US town being gripped by DEMENTIA epidemic: ‘Everybody’s got it’

Published: 01:45 EDT, 1 May 2025 | Updated: 08:26 EDT, 1 May 2025 While it might appear like just another sleepy border town, Rio Grande City in southern Texas has a dark secret. The community of just over 15,000 residents has one of the highest dementia rates in America.  One in four people here over the age of 65 have it compared to around […]

· In the News

Pastor recognized for her volunteerism in Alzheimer’s research

BY  SETH VOORHEES OSWEGO | spectrumlocalnews OWEGO, N.Y. — Nearly seven million Americans live with Alzheimer’s disease, and according to the National Institutes of Health, the number could grow by 50% by 2060. It’s a stunning number, but researchers say they’re making great progress in understanding and preventing the disease, which affects memory, thinking and behavior. An author and […]

· In the News

PR Newswire: iLoF and Industry Leader Hamamatsu Announce Strategic Investment in a Collaboration to Advance the Future of Personalized Medicine

iLoF, the leading innovator in AI-powered photonics platforms for personalised medicine, announces today a strategic investment from Hamamatsu, the world expert in the development and manufacturing of photonics devices and systems for medical optics and biophotonics, to further its mission of transforming healthcare and driving innovation in medicine. LONDON, Oct. 22, 2024 /PRNewswire/ — iLoF, the leading company […]

· In the News

Encuentros Interactivos: Dilenia Cruz recibe el reconocimiento Citizen Scientist Cultivator Honoree 2024 por su labor en salud cerebral

*”This story reposted in its entirely in the original posted language”*En un evento celebrado en la Conferencia de Optimización de Sitios GAP-Net 2025 en Miami, Florida, la Global Alzheimer’s Platform Foundation® reconoció a Dilenia Cruz como una de las figuras clave en la lucha contra enfermedades neurodegenerativas al otorgarle el prestigioso título de Citizen Scientist Cultivator […]

· In the News

NBC 4: Arlington woman shares young-onset Parkinson’s journey and advocates for research

Allison “Allie” Signorelli started sharing her journey with young-onset Parkinson’s on Instagram to create a community with others. Since then, she has joined research studies and teamed up with advocates to spread awareness. News4’s Molette Green reports.  View segment here: https://www.nbcwashington.com/community/in-the-community/arlington-woman-shares-young-onset-parkinsons-journey-and-advocates-for-research/3876476

· In the News

The Pathologist: No Alzheimer’s Patient Left Behind

A blood-based diagnostic test for neurodegenerative diseases is a global priority By Zivjena Vucetic 03/21/2025 As the global population ages, the incidence of neurodegenerative diseases such as Alzheimer’s disease (AD) is rapidly increasing. By 2050, the global population of people over the age of 60 is expected to double, reaching 2.1 billion individuals, while those over 80 […]

· In the News

Alliance for Aging Research: Alliance, Partnership to Fight Chronic Disease, and the Global Alzheimer’s Platform Foundation Comment on Accelerated Approval Guidances

By Aging Research, Published March 10, 2025 Aging Research The Alliance for Aging Research, the Partnership to Fight Chronic Disease (PFCD), and the Global Alzheimer’s Platform Foundation (GAP) submitted comments today on both of the recently issued draft guidances on accelerated approval—Expedited Programs for Serious Conditions—Accelerated Approval of Drugs and Biologics (hereafter the “Programmatic Guidance”) and Accelerated Approval and Considerations for […]

To top